ART - antiretroviral therapy
(New York Times) ICAP’s Wafaa El-Sadr on Universal “Test and Treat” for HIV
Imagine that 90 percent of all people living with HIV were diagnosed and treated with drugs. Would that be sufficient to end the AIDS epidemic? Scientists tried to answer the question in three enormous studies published on Wednesday in the New England Journal of...
In Ethiopia, A Focus on Multi-Month ART Scripting at Scale Pays Off
As ministries of health and their partners move to scale up differentiated service delivery (DSD) for HIV treatment, one approach is taking the spotlight. Multi-month scripting (MMS) is a facility-based, individual-focused DSD model, in which recipients of care who...
ICAP and PEPFAR Release Adaptable Training Package for Dolutegravir Transition
ICAP at Columbia University, in partnership with the President’s Emergency Plan for AIDS Relief (PEPFAR), through the USAID-funded OPTIMIZE Project, has developed a health care worker training package for countries transitioning to dolutegravir (DTG)-based regimens...